Dr. Reddy’s Laboratories launches Methylprednisolone Sodium Succinate for Injection

05 Apr 2022 Evaluate

Dr. Reddy’s Laboratories has launched Methylprednisolone Sodium Succinate for Injection, USP, the generic equivalent of SOLU-MEDROL (methylprednisolone sodium succinate for injection, USP) in the U.S. Market approved by the U.S. Food and Drug Administration (USFDA).

The SOLU-MEDROL brand and generic had U.S. sales of around $144 million MAT for the most recent twelve months ending in February 2022 according to IQVIA Health.

Dr. Reddy’s Methylprednisolone Sodium Succinate for Injection, USP, is supplied in 40 mg/vial, 125 mg/vial single-dose vials each carton containing 25 vials; 500 mg and 1 gm multi-dose vial each carton containing 1 vial.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1285.45 -33.45 (-2.54%)
27-Feb-2026 12:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1764.20
Dr. Reddys Lab 1285.45
Cipla 1342.15
Zydus Lifesciences 921.15
Lupin 2296.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×